| Field | Row 1 |
|---|---|
| adsh | 0001062993-25-009081 |
| cik | 720875 |
| name | DYNATRONICS CORP |
| sic | 3841 |
| countryba | US |
| stprba | UT |
| cityba | SALT LAKE CITY |
| zipba | 84121 |
| bas1 | 7030 PARK CENTRE DRIVE |
| bas2 | BLDG D |
| baph | 8015687000 |
| countryma | US |
| stprma | UT |
| cityma | SALT LAKE CITY |
| zipma | 84121 |
| mas1 | 7030 PARK CENTER DR |
| mas2 | |
| countryinc | US |
| stprinc | UT |
| ein | 870398434 |
| former | DYNATRONICS LASER CORP |
| changed | 19920703 |
| afs | 4-NON |
| wksi | 0 |
| fye | 0630 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q3 |
| filed | 20250512 |
| accepted | 2025-05-12 16:00:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | form10q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001062993-25-009081 | 20240630 | Allowance For Doubtful Accounts Receivable Current | 48997.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Accounts Payable Current | 3699380.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Accounts Receivable Net Current | 2837232.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Assets Current | 10557635.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20230630 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 552870.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Common Stock Value | 35632036.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Cost Of Revenue | 19218072.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Deferred Gain Net Of Current Portion | 514030.0000 | USD | 0 | 0001062993-25-009081 | |||
| 0001062993-25-009081 | 20240331 | Depreciation And Amortization | 520051.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Gain Loss On Sale Of Property Plant Equipment | -41389.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Gross Profit | 1096302.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 771569.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Liabilities And Stockholders Equity | 23448289.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Liabilities Current | 7704910.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Lines Of Credit Current | 2121667.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Lines Of Credit Current | 1851198.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Operating Income Loss | -1713157.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Operating Income Loss | -1861850.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Revenues | 25161111.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Revenues | 73566.0000 | USD | 3 | us-gaap/2024 | Product Or Service= Other; | ||
| 0001062993-25-009081 | 20240331 | Other Nonoperating Income Expense | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Other Nonoperating Income Expense | 40670.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20231231 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 0.0000 | USD | 1 | 0001062993-25-009081 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20240630 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 158902.0000 | USD | 1 | 0001062993-25-009081 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240630 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | -158902.0000 | USD | 1 | 0001062993-25-009081 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20241231 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 0.0000 | USD | 1 | 0001062993-25-009081 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20240331 | Preferred Stock Dividend In Common Stock Issued To Be Issued | -183668.0000 | USD | 1 | 0001062993-25-009081 | |||
| 0001062993-25-009081 | 20250331 | Preferred Stock Dividend In Common Stock Issued To Be Issued | -541327.0000 | USD | 3 | 0001062993-25-009081 | |||
| 0001062993-25-009081 | 20240630 | Preferred Stock Shares Issued | 3351000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Preferred Stock Value | 7980788.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Profit Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20240630 | Profit Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20240630 | Profit Loss | -687927.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20240930 | Profit Loss | -366648.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20240331 | Provision For Doubtful Accounts | -71999.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Revenues | 3656363.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Physical Therapy And Rehabilitation Products; | ||
| 0001062993-25-009081 | 20240331 | Revenues | 12464521.0000 | USD | 3 | us-gaap/2024 | Product Or Service= Orthopedic Soft Bracing Products; | ||
| 0001062993-25-009081 | 20240331 | Revenues | 12631415.0000 | USD | 3 | us-gaap/2024 | Product Or Service= Physical Therapy And Rehabilitation Products; | ||
| 0001062993-25-009081 | 20240331 | Share Based Compensation | -1166.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20231231 | Shares Issued | 4530837.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240630 | Shares Issued | 5308519.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20230930 | Stock Dividends Shares | 201656.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20230930 | Stock Granted During Period Value Sharebased Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20240331 | Stock Granted During Period Value Sharebased Compensation | -16492.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240331 | Stock Granted During Period Value Sharebased Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20240630 | Stock Granted During Period Value Sharebased Compensation | 2804.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Stock Granted During Period Value Sharebased Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20240930 | Stock Granted During Period Value Sharebased Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20241231 | Stock Granted During Period Value Sharebased Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20250331 | Stock Granted During Period Value Sharebased Compensation | 484.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20230930 | Stockholders Equity | 7980788.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20230930 | Stockholders Equity | -26007290.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20240930 | Stockholders Equity | 7980788.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 4878512.0000 | shares | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Preferred Stock Shares Issued | 3351000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Accounts Receivable Net Current | 3444587.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Amortization Of Deferred Gain On Sale Leaseback | 112836.0000 | USD | 3 | 0001062993-25-009081 | |||
| 0001062993-25-009081 | 20250331 | Common Stock Shares Issued | 8810332.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Common Stock Shares Outstanding | 8810332.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Depreciation And Amortization | 372662.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Earnings Per Share Diluted | -0.1700 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Earnings Per Share Diluted | -0.1300 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Employee Related Liabilities Current | 302601.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -2012575.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -2131233.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Income Tax Expense Benefit | -2783.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Interest Expense | 308383.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Interest Paid Net | 192172.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Net Cash Provided By Used In Financing Activities | -496122.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Net Cash Provided By Used In Operating Activities | 216606.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Nonoperating Income Expense | -269383.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Operating Lease Liability Noncurrent | 1380605.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Other Assets | 374595.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Other Receivables Net Current | 454390.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 0.0000 | USD | 1 | 0001062993-25-009081 | |||
| 0001062993-25-009081 | 20240930 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 0.0000 | USD | 1 | 0001062993-25-009081 | |||
| 0001062993-25-009081 | 20240630 | Prepaid Expense Current | 530356.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20230930 | Profit Loss | -330654.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Profit Loss | -667722.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20241231 | Profit Loss | -774827.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20250331 | Profit Loss | -999062.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Profit Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20250331 | Profit Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20240331 | Revenues | 7657846.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Revenues | 6151516.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Revenues | 3310768.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Physical Therapy And Rehabilitation Products; | ||
| 0001062993-25-009081 | 20250331 | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 467842.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20230930 | Shares Issued | 3351000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20230930 | Stock Granted During Period Value Sharebased Compensation | 19173.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240331 | Stock Granted During Period Value Sharebased Compensation | -16492.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Stock Granted During Period Value Sharebased Compensation | 2804.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20230630 | Stockholders Equity | 34355315.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20231231 | Stockholders Equity | 34758943.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240331 | Stockholders Equity | -28061340.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20241231 | Stockholders Equity | -30402994.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20250331 | Stockholders Equity | 12022791.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Stockholders Equity | 35632036.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240331 | Stock Issued During Period Shares Share Based Compensation | 10154.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240630 | Stock Issued During Period Shares Share Based Compensation | 0.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20250331 | Amortization Of Intangible Assets | 463725.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Assets | 23448289.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 595618.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 534328.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Earnings Per Share Basic | -0.1300 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Goodwill | 7116614.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Gross Profit | 4721628.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Increase Decrease In Accounts Payable And Accrued Liabilities | -1542806.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Increase Decrease In Other Operating Assets | -333530.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | -161002.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Intangible Assets Net Excluding Goodwill | 2999975.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Liabilities | 11425498.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Liabilities And Stockholders Equity | 25940559.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Net Cash Provided By Used In Investing Activities | -241014.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Net Income Loss | -2009792.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Operating Lease Right Of Use Asset | 2831417.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Other Nonoperating Income Expense | 0.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Payments To Acquire Property Plant And Equipment | 241014.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 0.0000 | USD | 1 | 0001062993-25-009081 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20240930 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 167738.0000 | USD | 1 | 0001062993-25-009081 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20250331 | Preferred Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Preferred Stock Shares Outstanding | 1359000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series B Preferred Stock; | ||
| 0001062993-25-009081 | 20231231 | Profit Loss | -1011416.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Profit Loss | -667722.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20241231 | Profit Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20250331 | Provision For Doubtful Accounts | 21488.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Retained Earnings Accumulated Deficit | -28908169.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Revenues | 3980170.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Orthopedic Soft Bracing Products; | ||
| 0001062993-25-009081 | 20250331 | Selling General And Administrative Expense | 2040624.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20231231 | Stock Granted During Period Value Sharebased Compensation | -3848.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240630 | Stock Granted During Period Value Sharebased Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20240930 | Stock Granted During Period Value Sharebased Compensation | 1200.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20250331 | Stock Granted During Period Value Sharebased Compensation | 484.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Stock Granted During Period Value Sharebased Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20230630 | Stockholders Equity | 7980788.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20240630 | Stockholders Equity | 7980788.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20240930 | Stockholders Equity | -29442555.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20250331 | Stockholders Equity | 7980788.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 8793057.0000 | shares | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 4553847.0000 | shares | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Current Portion Of Deferred Gain | 150448.0000 | USD | 0 | 0001062993-25-009081 | |||
| 0001062993-25-009081 | 20240630 | Accounts Payable Current | 2712142.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Amortization Of Intangible Assets | 463725.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Deferred Gain Net Of Current Portion | 626866.0000 | USD | 0 | 0001062993-25-009081 | |||
| 0001062993-25-009081 | 20250331 | Earnings Per Share Diluted | -0.3700 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Finance Lease Liability Noncurrent | 1190241.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Finance Lease Principal Payments | 213383.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Gross Profit | 5943039.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -999062.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Increase Decrease In Accounts Payable And Accrued Liabilities | 638931.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Intangible Assets Net Excluding Goodwill | 2536250.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Inventory Net | 5466794.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Inventory Write Down | 151390.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Net Income Loss | -667722.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Net Income Loss Available To Common Stockholders Basic | -1187039.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Other Assets | 465505.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued | 541327.0000 | USD | 3 | 0001062993-25-009081 | |||
| 0001062993-25-009081 | 20230930 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | -197059.0000 | USD | 1 | 0001062993-25-009081 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20231231 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 0.0000 | USD | 1 | 0001062993-25-009081 | |||
| 0001062993-25-009081 | 20231231 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 191244.0000 | USD | 1 | 0001062993-25-009081 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240331 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | -183668.0000 | USD | 1 | 0001062993-25-009081 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20240630 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 0.0000 | USD | 1 | 0001062993-25-009081 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20240630 | Preferred Stock Shares Authorized | 50000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Product Warranty Accrual Classified Current | 104803.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20230930 | Profit Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20230930 | Profit Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20240630 | Profit Loss | -687927.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Property Plant And Equipment Net | 1969413.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Revenues | 21313.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Other; | ||
| 0001062993-25-009081 | 20230930 | Shares Issued | 4260039.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20241231 | Shares Issued | 3351000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20241231 | Stock Dividends Shares | 1359299.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20250331 | Stock Dividends Shares | 1546769.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240331 | Stock Granted During Period Value Sharebased Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20241231 | Stock Granted During Period Value Sharebased Compensation | 1200.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20230630 | Stockholders Equity | 16856526.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Stockholders Equity | 7980788.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20240630 | Stockholders Equity | -28908169.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20240930 | Stockholders Equity | 35256763.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20241231 | Stockholders Equity | 13021369.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Stock Issued During Period Shares Share Based Compensation | 8000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 4878512.0000 | shares | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 8793057.0000 | shares | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 7302201.0000 | shares | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Product Warranty Accrual Classified Current | 120677.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Accrued Liabilities Current | 671861.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Amortization Of Deferred Gain On Sale Leaseback | 112836.0000 | USD | 3 | 0001062993-25-009081 | |||
| 0001062993-25-009081 | 20250331 | Cash And Cash Equivalents At Carrying Value | 174090.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 224500.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001062993-25-009081 | 20240630 | Common Stock Shares Outstanding | 5308519.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Current Portion Of Deferred Gain | 150448.0000 | USD | 0 | 0001062993-25-009081 | |||
| 0001062993-25-009081 | 20250331 | Earnings Per Share Basic | -0.3700 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Finance Lease Liability Current | 315975.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Goodwill | 7116614.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Gross Profit | 1817117.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Income Tax Expense Benefit | -13526.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Increase Decrease In Other Operating Assets | -90910.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Inventory Write Down | -25941.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Liabilities Current | 8165486.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Operating Lease Liability Noncurrent | 1829608.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Payments To Acquire Property Plant And Equipment | 30312.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20230930 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 0.0000 | USD | 1 | 0001062993-25-009081 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20231231 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | -191244.0000 | USD | 1 | 0001062993-25-009081 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20240930 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 0.0000 | USD | 1 | 0001062993-25-009081 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20241231 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 185612.0000 | USD | 1 | 0001062993-25-009081 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20250331 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 0.0000 | USD | 1 | 0001062993-25-009081 | |||
| 0001062993-25-009081 | 20250331 | Preferred Stock Dividend In Common Stock Issued To Be Issued | -187977.0000 | USD | 1 | 0001062993-25-009081 | |||
| 0001062993-25-009081 | 20231231 | Profit Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20240331 | Profit Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240630 | Profit Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20241231 | Profit Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20240630 | Accrued Liabilities Current | 725727.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Allowance For Doubtful Accounts Receivable Current | 70485.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Cash And Cash Equivalents At Carrying Value | 483918.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -309828.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Common Stock No Par Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Common Stock Shares Authorized | 100000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Cost Of Revenue | 5055214.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Cost Of Revenue | 16332361.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Earnings Per Share Basic | -0.1700 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Finance Lease Liability Noncurrent | 1428870.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Finance Lease Principal Payments | 225653.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Income Tax Expense Benefit | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Increase Decrease In Inventories | -153121.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Interest Expense | 109292.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Interest Expense | 299418.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Net Income Loss Available To Common Stockholders Basic | -851390.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Operating Income Loss | -944322.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Operating Lease Liability Current | 1004808.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Other Nonoperating Income Expense | 39000.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20241231 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 0.0000 | USD | 1 | 0001062993-25-009081 | |||
| 0001062993-25-009081 | 20250331 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 187977.0000 | USD | 1 | 0001062993-25-009081 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240630 | Preferred Stock No Par Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Preferred Stock Shares Outstanding | 3351000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Preferred Stock Shares Outstanding | 1992000.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001062993-25-009081 | 20230930 | Profit Loss | -330654.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20231231 | Profit Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240930 | Profit Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20250331 | Property Plant And Equipment Net | 1622482.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Retained Earnings Accumulated Deficit | -31590033.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Revenues | 11554808.0000 | USD | 3 | us-gaap/2024 | Product Or Service= Physical Therapy And Rehabilitation Products; | ||
| 0001062993-25-009081 | 20240331 | Selling General And Administrative Expense | 2389073.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Selling General And Administrative Expense | 7656196.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20230630 | Shares Issued | 4044984.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240331 | Shares Issued | 3351000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20240630 | Shares Issued | 3351000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20240930 | Shares Issued | 5896264.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240331 | Stockholders Equity | 14845567.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Stockholders Equity | 14160444.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240930 | Stockholders Equity | 13794996.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Restricted Cash | 50410.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Revenues | 65175.0000 | USD | 3 | us-gaap/2024 | Product Or Service= Other; | ||
| 0001062993-25-009081 | 20250331 | Revenues | 2816762.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Orthopedic Soft Bracing Products; | ||
| 0001062993-25-009081 | 20250331 | Revenues | 9425615.0000 | USD | 3 | us-gaap/2024 | Product Or Service= Orthopedic Soft Bracing Products; | ||
| 0001062993-25-009081 | 20250331 | Share Based Compensation | 2884.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Shares Issued | 4882375.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240331 | Stock Dividends Shares | 341384.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20231231 | Stock Granted During Period Value Sharebased Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20231231 | Stock Granted During Period Value Sharebased Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20240930 | Stock Granted During Period Value Sharebased Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20241231 | Stock Granted During Period Value Sharebased Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20230930 | Stockholders Equity | 16545045.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20230930 | Stockholders Equity | 34571547.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20231231 | Stockholders Equity | 7980788.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20231231 | Stockholders Equity | -27209950.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20240331 | Stockholders Equity | 34926119.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20241231 | Stockholders Equity | 7980788.0000 | USD | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 7302201.0000 | shares | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Assets | 25940559.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Assets Current | 9352270.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 42748.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001062993-25-009081 | 20240630 | Common Stock No Par Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Common Stock Shares Authorized | 100000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Common Stock Shares Issued | 5308519.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Common Stock Value | 35087825.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Cost Of Revenue | 5840729.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Earnings Per Share Basic | -0.5700 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Gain Loss On Sale Of Property Plant Equipment | -5330.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -681248.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Increase Decrease In Accounts Receivable | -77378.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Increase Decrease In Inventories | -1067812.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Interest Paid Net | 455932.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Inventory Net | 5593974.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Liabilities | 11780115.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Net Cash Provided By Used In Investing Activities | -30312.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Net Cash Provided By Used In Operating Activities | -1854893.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Net Income Loss Available To Common Stockholders Basic | -2581763.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Net Income Loss Available To Common Stockholders Basic | -2681864.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Nonoperating Income Expense | -54740.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Other Liabilities Noncurrent | 189861.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Other Liabilities Noncurrent | 175136.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Other Receivables Net Current | 178514.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20230930 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 0.0000 | USD | 1 | 0001062993-25-009081 | |||
| 0001062993-25-009081 | 20230930 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 197059.0000 | USD | 1 | 0001062993-25-009081 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240331 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 183668.0000 | USD | 1 | 0001062993-25-009081 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20241231 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | -185612.0000 | USD | 1 | 0001062993-25-009081 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20250331 | Preferred Stock No Par Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Preferred Stock Shares Outstanding | 3351000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Prepaid Expense Current | 645230.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Proceeds From Repayments Of Lines Of Credit | -270469.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240930 | Profit Loss | -366648.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240930 | Profit Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20241231 | Profit Loss | -774827.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Profit Loss | -999062.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20250331 | Revenues | 23986.0000 | USD | 1 | us-gaap/2024 | Product Or Service= Other; | ||
| 0001062993-25-009081 | 20250331 | Revenues | 21053989.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | 35366.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20230630 | Shares Issued | 3351000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20231231 | Shares Issued | 3351000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20250331 | Shares Issued | 8810332.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20250331 | Shares Issued | 3351000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20240630 | Stock Dividends Shares | 426144.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240930 | Stock Dividends Shares | 575745.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20230930 | Stock Granted During Period Value Sharebased Compensation | 19173.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20230930 | Stock Granted During Period Value Sharebased Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20231231 | Stock Granted During Period Value Sharebased Compensation | -3848.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20241231 | Stock Granted During Period Value Sharebased Compensation | 1200.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20230630 | Stockholders Equity | -25479577.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20240630 | Stockholders Equity | 35087825.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20241231 | Stockholders Equity | 35443575.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20250331 | Stockholders Equity | -31590033.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20231231 | Stock Issued During Period Shares Share Based Compensation | 8080.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240930 | Stock Issued During Period Shares Share Based Compensation | 12000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240331 | Earnings Per Share Diluted | -0.5700 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Employee Related Liabilities Current | 566443.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240630 | Finance Lease Liability Current | 302998.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Income Tax Expense Benefit | 9304.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Increase Decrease In Accounts Receivable | -585867.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Interest Expense | 95410.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Net Cash Provided By Used In Financing Activities | 2138655.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Net Income Loss | -999062.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Net Income Loss | -2140537.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Nonoperating Income Expense | -109292.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Nonoperating Income Expense | -299418.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Operating Income Loss | -571956.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Operating Lease Liability Current | 1069220.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Operating Lease Right Of Use Asset | 2446078.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued | 571971.0000 | USD | 3 | 0001062993-25-009081 | |||
| 0001062993-25-009081 | 20240331 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 0.0000 | USD | 1 | 0001062993-25-009081 | |||
| 0001062993-25-009081 | 20240930 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | -167738.0000 | USD | 1 | 0001062993-25-009081 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20250331 | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | -187977.0000 | USD | 1 | 0001062993-25-009081 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20240331 | Preferred Stock Dividend In Common Stock Issued To Be Issued | -571971.0000 | USD | 3 | 0001062993-25-009081 | |||
| 0001062993-25-009081 | 20250331 | Preferred Stock Value | 7980788.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240331 | Proceeds From Repayments Of Lines Of Credit | 2352038.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20231231 | Profit Loss | -1011416.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20240630 | Restricted Cash | 50410.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Selling General And Administrative Expense | 6583478.0000 | USD | 3 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20240930 | Shares Issued | 3351000.0000 | shares | 0 | us-gaap/2024 | Equity Components= Preferred Stock; | ||
| 0001062993-25-009081 | 20241231 | Shares Issued | 7255563.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20231231 | Stock Dividends Shares | 262718.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240930 | Stock Granted During Period Value Sharebased Compensation | 1200.0000 | USD | 1 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20250331 | Stock Granted During Period Value Sharebased Compensation | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001062993-25-009081 | 20231231 | Stockholders Equity | 15529781.0000 | USD | 0 | us-gaap/2024 | |||
| 0001062993-25-009081 | 20230930 | Stock Issued During Period Shares Share Based Compensation | 13399.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20241231 | Stock Issued During Period Shares Share Based Compensation | 0.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001062993-25-009081 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 4553847.0000 | shares | 3 | us-gaap/2024 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Operating Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. |
| Depreciation And Amortization | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation, Depletion and Amortization, Nonproduction | The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. |
| Payments To Acquire Property Plant And Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. |
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | us-gaap/2024 | 0 | 0 | monetary | D | D | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | Amount of increase in right-of-use asset obtained in exchange for operating lease liability. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Allowance For Doubtful Accounts Receivable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Receivable, Allowance for Credit Loss, Current | Amount of allowance for credit loss on accounts receivable, classified as current. |
| Finance Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Finance Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Preferred Stock Dividend In Common Stock Issued To Be Issued | 0001062993-25-009081 | 1 | 0 | monetary | D | C | Preferred Stock Dividend In Common Stock Issued To Be Issued | Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock. |
| Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Prepaid Expense Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Current Portion Of Deferred Gain | 0001062993-25-009081 | 1 | 0 | monetary | I | C | Current portion of deferred gain | Represents the monetary amount of current portion of deferred gain, as of the indicated date. |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Gross Profit | us-gaap/2024 | 0 | 0 | monetary | D | C | Gross Profit | Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. |
| Interest Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Interest Expense, Operating and Nonoperating | Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. |
| Lines Of Credit Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Line of Credit, Current | The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement. |
| Operating Lease Right Of Use Asset | us-gaap/2024 | 0 | 0 | monetary | I | D | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. |
| Product Warranty Accrual Classified Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Product Warranty Accrual, Current | Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Shares, Issued | Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. | |
| Accrued Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Cost Of Revenue | us-gaap/2024 | 0 | 0 | monetary | D | D | Cost of Revenue | The aggregate cost of goods produced and sold and services rendered during the reporting period. |
| Finance Lease Principal Payments | us-gaap/2024 | 0 | 0 | monetary | D | C | Finance Lease, Principal Payments | Amount of cash outflow for principal payment on finance lease. |
| Increase Decrease In Other Operating Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Other Operating Assets | Amount of increase (decrease) in operating assets classified as other. |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Proceeds From Repayments Of Lines Of Credit | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from (Repayments of) Lines of Credit | The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets). |
| Selling General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | Selling, General and Administrative Expense | The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Increase Decrease In Inventories | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Inventories | The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Inventory Write Down | us-gaap/2024 | 0 | 0 | monetary | D | D | Inventory Write-down | Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels. |
| Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Nonoperating Income (Expense) | The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Profit Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. |
| Employee Related Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Employee-related Liabilities, Current | Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Common Stock No Par Value | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, No Par Value | Face amount per share of no-par value common stock. | |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Goodwill | Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. |
| Intangible Assets Net Excluding Goodwill | us-gaap/2024 | 0 | 0 | monetary | I | D | Intangible Assets, Net (Excluding Goodwill) | Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Stock Granted During Period Value Sharebased Compensation | us-gaap/2024 | 0 | 0 | monetary | D | C | Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). |
| Other Liabilities Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. |
| Restricted Cash | us-gaap/2024 | 0 | 0 | monetary | I | D | Restricted Cash | Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Preferred Stock Dividend In Common Stock Issued Or To Be Issued | 0001062993-25-009081 | 1 | 0 | monetary | D | D | [Preferred stock dividend, in common stock, issued or to be issued] | |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Inventory Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Inventory, Net | Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. |
| Revenues | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Amortization Of Deferred Gain On Sale Leaseback | 0001062993-25-009081 | 1 | 0 | monetary | D | C | Amortization of deferred gain on sale/leaseback | |
| Amortization Of Intangible Assets | us-gaap/2024 | 0 | 0 | monetary | D | D | Amortization of Intangible Assets | The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Gain Loss On Sale Of Property Plant Equipment | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss) on Disposition of Property Plant Equipment | Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property. |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Net Income Loss Available To Common Stockholders Basic | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Available to Common Stockholders, Basic | Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. |
| Deferred Gain Net Of Current Portion | 0001062993-25-009081 | 1 | 0 | monetary | I | C | Deferred gain, net of current portion | Represents the monetary amount of deferred gain, net of current portion, as of the indicated date. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable and Accrued Liabilities | The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid. |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Other Receivables Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Receivables, Net, Current | Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer. |
| Preferred Stock No Par Value | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, No Par Value | Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Stock Dividends Shares | us-gaap/2024 | 0 | 0 | shares | D | Stock Dividends, Shares | Number of shares of common and preferred stock issued as dividends during the period. Excludes stock splits. | |
| Finance Lease Liability Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Finance Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from finance lease, classified as current. |
| Operating Lease Liability Noncurrent | us-gaap/2024 | 0 | 0 | monetary | I | C | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. |
| Other Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Other Assets | Amount of assets classified as other. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Provision For Doubtful Accounts | us-gaap/2024 | 0 | 0 | monetary | D | D | Accounts Receivable, Credit Loss Expense (Reversal) | Amount of expense (reversal of expense) for expected credit loss on accounts receivable. |
| Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | 0 | 0 | shares | D | Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture | Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). | |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | |
| Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 0001062993-25-009081 | 1 | 0 | monetary | D | D | Preferred stock dividend, in common stock, issued or to be issued, amount |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001062993-25-009081 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001062993-25-009081 | 2 | 4 | BS | 0 | H | Restricted Cash | us-gaap/2024 | Restricted cash | 0 |
| 0001062993-25-009081 | 2 | 5 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Trade accounts receivable, less allowance for credit losses of $70,485 and $48,997 as of March 31, 2025 and June 30, 2024, respectively | 0 |
| 0001062993-25-009081 | 2 | 6 | BS | 0 | H | Other Receivables Net Current | us-gaap/2024 | Other receivables | 0 |
| 0001062993-25-009081 | 2 | 7 | BS | 0 | H | Inventory Net | us-gaap/2024 | Inventories, net | 0 |
| 0001062993-25-009081 | 2 | 8 | BS | 0 | H | Prepaid Expense Current | us-gaap/2024 | Prepaid expenses | 0 |
| 0001062993-25-009081 | 2 | 9 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001062993-25-009081 | 2 | 10 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0001062993-25-009081 | 2 | 11 | BS | 0 | H | Operating Lease Right Of Use Asset | us-gaap/2024 | Operating lease assets | 0 |
| 0001062993-25-009081 | 2 | 12 | BS | 0 | H | Intangible Assets Net Excluding Goodwill | us-gaap/2024 | Intangible assets, net | 0 |
| 0001062993-25-009081 | 2 | 13 | BS | 0 | H | Goodwill | us-gaap/2024 | Goodwill | 0 |
| 0001062993-25-009081 | 2 | 14 | BS | 0 | H | Other Assets | us-gaap/2024 | Other assets | 0 |
| 0001062993-25-009081 | 2 | 15 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001062993-25-009081 | 2 | 18 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001062993-25-009081 | 2 | 19 | BS | 0 | H | Employee Related Liabilities Current | us-gaap/2024 | Accrued payroll and benefits expense | 0 |
| 0001062993-25-009081 | 2 | 20 | BS | 0 | H | Accrued Liabilities Current | us-gaap/2024 | Accrued expense | 0 |
| 0001062993-25-009081 | 2 | 21 | BS | 0 | H | Product Warranty Accrual Classified Current | us-gaap/2024 | Warranty reserve | 0 |
| 0001062993-25-009081 | 2 | 22 | BS | 0 | H | Lines Of Credit Current | us-gaap/2024 | Line of credit | 0 |
| 0001062993-25-009081 | 2 | 23 | BS | 0 | H | Finance Lease Liability Current | us-gaap/2024 | Current portion of finance lease liability | 0 |
| 0001062993-25-009081 | 2 | 24 | BS | 0 | H | Current Portion Of Deferred Gain | 0001062993-25-009081 | Current portion of deferred gain | 0 |
| 0001062993-25-009081 | 2 | 25 | BS | 0 | H | Operating Lease Liability Current | us-gaap/2024 | Current portion of operating lease liability | 0 |
| 0001062993-25-009081 | 2 | 26 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001062993-25-009081 | 2 | 27 | BS | 0 | H | Finance Lease Liability Noncurrent | us-gaap/2024 | Finance lease liability, net of current portion | 0 |
| 0001062993-25-009081 | 2 | 28 | BS | 0 | H | Deferred Gain Net Of Current Portion | 0001062993-25-009081 | Deferred gain, net of current portion | 0 |
| 0001062993-25-009081 | 2 | 29 | BS | 0 | H | Operating Lease Liability Noncurrent | us-gaap/2024 | Operating lease liability, net of current portion | 0 |
| 0001062993-25-009081 | 2 | 30 | BS | 0 | H | Other Liabilities Noncurrent | us-gaap/2024 | Other liabilities | 0 |
| 0001062993-25-009081 | 2 | 31 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001062993-25-009081 | 2 | 32 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies | 0 |
| 0001062993-25-009081 | 2 | 34 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, no par value: Authorized 50,000,000 shares; 3,351,000 shares issued and outstanding as of March 31, 2025 and June 30, 2024, respectively | 0 |
| 0001062993-25-009081 | 2 | 35 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, no par value: Authorized 100,000,000 shares; 8,810,332 shares and 5,308,519 shares issued and outstanding as of March 31, 2025 and June 30, 2024, respectively | 0 |
| 0001062993-25-009081 | 2 | 36 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001062993-25-009081 | 2 | 37 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders' equity | 0 |
| 0001062993-25-009081 | 2 | 38 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities and stockholders' equity | 0 |
| 0001062993-25-009081 | 3 | 1 | BS | 1 | H | Allowance For Doubtful Accounts Receivable Current | us-gaap/2024 | Allowance for Credit Losses | 0 |
| 0001062993-25-009081 | 3 | 2 | BS | 1 | H | Preferred Stock No Par Value | us-gaap/2024 | Preferred Stock, Par Value | 0 |
| 0001062993-25-009081 | 3 | 3 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred Stock, Shares Authorized | 0 |
| 0001062993-25-009081 | 3 | 4 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred Stock, Shares Issued | 0 |
| 0001062993-25-009081 | 3 | 5 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred Stock, Shares Outstanding | 0 |
| 0001062993-25-009081 | 3 | 6 | BS | 1 | H | Common Stock No Par Value | us-gaap/2024 | Common Stock, Par Value | 0 |
| 0001062993-25-009081 | 3 | 7 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common Stock, Shares Authorized | 0 |
| 0001062993-25-009081 | 3 | 8 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common Stock, Shares Issued | 0 |
| 0001062993-25-009081 | 3 | 9 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common Stock, Shares Outstanding | 0 |
| 0001062993-25-009081 | 4 | 1 | IS | 0 | H | Revenues | us-gaap/2024 | Net sales | 0 |
| 0001062993-25-009081 | 4 | 2 | IS | 0 | H | Cost Of Revenue | us-gaap/2024 | Cost of sales | 0 |
| 0001062993-25-009081 | 4 | 3 | IS | 0 | H | Gross Profit | us-gaap/2024 | Gross profit | 0 |
| 0001062993-25-009081 | 4 | 4 | IS | 0 | H | Selling General And Administrative Expense | us-gaap/2024 | Selling, general, and administrative expenses | 0 |
| 0001062993-25-009081 | 4 | 5 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Operating loss | 0 |
| 0001062993-25-009081 | 4 | 7 | IS | 0 | H | Interest Expense | us-gaap/2024 | Interest expense, net | 1 |
| 0001062993-25-009081 | 4 | 8 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Other income, net | 0 |
| 0001062993-25-009081 | 4 | 9 | IS | 0 | H | Nonoperating Income Expense | us-gaap/2024 | Net other expense | 0 |
| 0001062993-25-009081 | 4 | 10 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss before income taxes | 0 |
| 0001062993-25-009081 | 4 | 11 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Income tax benefit (provision) | 1 |
| 0001062993-25-009081 | 4 | 12 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001062993-25-009081 | 4 | 13 | IS | 0 | H | Preferred Stock Dividend In Common Stock Issued To Be Issued | 0001062993-25-009081 | Preferred stock dividend, in common stock, issued or to be issued | 0 |
| 0001062993-25-009081 | 4 | 14 | IS | 0 | H | Net Income Loss Available To Common Stockholders Basic | us-gaap/2024 | Net loss attributable to common stockholders | 0 |
| 0001062993-25-009081 | 4 | 16 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Net loss per common share Basic | 0 |
| 0001062993-25-009081 | 4 | 17 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Net loss per common share Diluted | 0 |
| 0001062993-25-009081 | 4 | 19 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Weighted average shares outstanding Basic | 0 |
| 0001062993-25-009081 | 4 | 20 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Weighted average shares outstanding Diluted | 0 |
| 0001062993-25-009081 | 5 | 8 | EQ | 0 | H | Shares Issued | us-gaap/2024 | Balance, shares | 0 |
| 0001062993-25-009081 | 5 | 9 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance, amount | 0 |
| 0001062993-25-009081 | 5 | 10 | EQ | 0 | H | Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | Stock-based compensation, shares | 0 |
| 0001062993-25-009081 | 5 | 11 | EQ | 0 | H | Stock Granted During Period Value Sharebased Compensation | us-gaap/2024 | Stock-based compensation, amount | 0 |
| 0001062993-25-009081 | 5 | 12 | EQ | 0 | H | Stock Dividends Shares | us-gaap/2024 | Preferred stock dividend, in common stock, issued or to be issued, shares | 0 |
| 0001062993-25-009081 | 5 | 13 | EQ | 0 | H | Preferred Stock Dividend In Common Stock Issued Or To Be Issued Amount | 0001062993-25-009081 | Preferred stock dividend, in common stock, issued or to be issued, amount | 0 |
| 0001062993-25-009081 | 5 | 14 | EQ | 0 | H | Profit Loss | us-gaap/2024 | Net loss | 0 |
| 0001062993-25-009081 | 5 | 15 | EQ | 0 | H | Shares Issued | us-gaap/2024 | Balance, shares | 0 |
| 0001062993-25-009081 | 5 | 16 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance, amount | 0 |
| 0001062993-25-009081 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001062993-25-009081 | 6 | 4 | CF | 0 | H | Depreciation And Amortization | us-gaap/2024 | Depreciation and amortization of property and equipment | 0 |
| 0001062993-25-009081 | 6 | 5 | CF | 0 | H | Amortization Of Intangible Assets | us-gaap/2024 | Amortization of intangible assets | 0 |
| 0001062993-25-009081 | 6 | 6 | CF | 0 | H | Gain Loss On Sale Of Property Plant Equipment | us-gaap/2024 | Loss on sale of property | 1 |
| 0001062993-25-009081 | 6 | 7 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0001062993-25-009081 | 6 | 8 | CF | 0 | H | Provision For Doubtful Accounts | us-gaap/2024 | Change in allowance for credit losses | 0 |
| 0001062993-25-009081 | 6 | 9 | CF | 0 | H | Inventory Write Down | us-gaap/2024 | Change in allowance for inventory obsolescence | 0 |
| 0001062993-25-009081 | 6 | 10 | CF | 0 | H | Amortization Of Deferred Gain On Sale Leaseback | 0001062993-25-009081 | Amortization of deferred gain on sale/leaseback | 1 |
| 0001062993-25-009081 | 6 | 12 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Trade accounts receivable | 1 |
| 0001062993-25-009081 | 6 | 13 | CF | 0 | H | Increase Decrease In Inventories | us-gaap/2024 | Inventories | 1 |
| 0001062993-25-009081 | 6 | 14 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other receivables | 1 |
| 0001062993-25-009081 | 6 | 15 | CF | 0 | H | Increase Decrease In Other Operating Assets | us-gaap/2024 | Other assets | 1 |
| 0001062993-25-009081 | 6 | 16 | CF | 0 | H | Increase Decrease In Accounts Payable And Accrued Liabilities | us-gaap/2024 | Accounts payable, accrued expenses, and other current liabilities | 0 |
| 0001062993-25-009081 | 6 | 17 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash provided by (used in) operating activities | 0 |
| 0001062993-25-009081 | 6 | 19 | CF | 0 | H | Payments To Acquire Property Plant And Equipment | us-gaap/2024 | Purchase of property and equipment | 1 |
| 0001062993-25-009081 | 6 | 20 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash used in investing activities | 0 |
| 0001062993-25-009081 | 6 | 22 | CF | 0 | H | Finance Lease Principal Payments | us-gaap/2024 | Principal payments on finance lease liability | 1 |
| 0001062993-25-009081 | 6 | 23 | CF | 0 | H | Proceeds From Repayments Of Lines Of Credit | us-gaap/2024 | Net change in line of credit | 0 |
| 0001062993-25-009081 | 6 | 24 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash (used in) provided by financing activities | 0 |
| 0001062993-25-009081 | 6 | 25 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net change in cash and cash equivalents and restricted cash | 0 |
| 0001062993-25-009081 | 6 | 26 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents and restricted cash at beginning of the period | 0 |
| 0001062993-25-009081 | 6 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents and restricted cash at end of the period | 0 |
| 0001062993-25-009081 | 6 | 29 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest | 0 |
| 0001062993-25-009081 | 6 | 31 | CF | 0 | H | Preferred Stock Dividend In Common Stock Issued Or To Be Issued | 0001062993-25-009081 | Preferred stock dividend, in common stock, issued or to be issued | 0 |
| 0001062993-25-009081 | 6 | 32 | CF | 0 | H | Right Of Use Asset Obtained In Exchange For Operating Lease Liability | us-gaap/2024 | Operating lease right-of-use assets obtained in exchange for lease obligations | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |